- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.97 Å
- Oligo State
- homo-dimer
- Ligands
- 9 x GOL: GLYCEROL(Non-functional Binders)
- 1 x G16: 1,6-di-O-phosphono-alpha-D-glucopyranose(Non-covalent)
G16.5: 10 residues within 4Å:- Chain A: R.125, N.130, R.136, R.143, G.177, G.178, Q.179, I.180, S.181, D.183
15 PLIP interactions:15 interactions with chain A- Hydrogen bonds: A:R.125, A:R.125, A:N.130, A:R.136, A:R.136, A:G.178, A:Q.179, A:I.180, A:S.181, A:S.181, A:D.183, A:D.183
- Water bridges: A:G.177
- Salt bridges: A:R.136, A:R.143
- 4 x MG: MAGNESIUM ION(Non-covalent)
MG.7: 7 residues within 4Å:- Chain A: D.14, D.16, G.17, T.18, D.211, K.212, D.219
6 PLIP interactions:3 interactions with chain A, 3 Ligand-Water interactions- Metal complexes: A:D.14, A:D.16, A:D.211, H2O.1, H2O.2, H2O.4
MG.8: 6 residues within 4Å:- Chain A: F.223, T.224, D.225, P.226, T.228, G.230
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:F.223, A:D.225, A:T.228, A:T.228, H2O.6
MG.16: 6 residues within 4Å:- Chain B: D.14, D.16, G.17, T.18, D.211, K.212
6 PLIP interactions:3 interactions with chain B, 3 Ligand-Water interactions- Metal complexes: B:D.14, B:D.16, B:D.211, H2O.7, H2O.7, H2O.8
MG.17: 6 residues within 4Å:- Chain B: F.223, T.224, D.225, P.226, T.228, G.230
5 PLIP interactions:3 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.225, B:T.228, B:T.228, H2O.10, H2O.12
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- 3 x NA: SODIUM ION(Non-functional Binders)
NA.10: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)NA.11: 2 residues within 4Å:- Chain A: D.50, E.52
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:D.50
NA.18: 3 residues within 4Å:- Chain B: R.196, E.199, N.200
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:E.199
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Briso-Montiano, A. et al., Insight on molecular pathogenesis and pharmacochaperoning potential in phosphomannomutase 2 deficiency, provided by novel human phosphomannomutase 2 structures. J Inherit Metab Dis (2022)
- Release Date
- 2022-02-02
- Peptides
- Phosphomannomutase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.97 Å
- Oligo State
- homo-dimer
- Ligands
- 9 x GOL: GLYCEROL(Non-functional Binders)
- 1 x G16: 1,6-di-O-phosphono-alpha-D-glucopyranose(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 1 x CL: CHLORIDE ION(Non-functional Binders)
- 3 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Briso-Montiano, A. et al., Insight on molecular pathogenesis and pharmacochaperoning potential in phosphomannomutase 2 deficiency, provided by novel human phosphomannomutase 2 structures. J Inherit Metab Dis (2022)
- Release Date
- 2022-02-02
- Peptides
- Phosphomannomutase 2: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B